CUMYL-BC-HPMEGACLONE-221

CUMYL-BC-HPMEGACLONE-221 is a synthetic cannabinoid that has been identified in various designer drug products. It is part of a class of compounds that interact with the cannabinoid receptors in the endocannabinoid system.

Chemical Structure and Properties

CUMYL-BC-HPMEGACLONE-221 is chemically related to other synthetic cannabinoids. Its structure includes a cumyl group attached to a benzimidazole core, which is further connected to a cyclohexylmethyl side chain. The exact molecular formula and detailed chemical properties are essential for understanding its pharmacological effects and potential risks.

Pharmacology

As a synthetic cannabinoid, CUMYL-BC-HPMEGACLONE-221 acts on the CB1 and CB2 receptors in the endocannabinoid system. These receptors are primarily found in the central nervous system and immune system, respectively. The interaction with these receptors can lead to various psychoactive effects, including euphoria, altered perception, and relaxation.

Legal Status

The legal status of CUMYL-BC-HPMEGACLONE-221 varies by country. In some regions, it may be classified as a controlled substance due to its potential for abuse and lack of medical use. It is important to consult local regulations to determine its legal status.

Health Risks and Safety

The use of synthetic cannabinoids like CUMYL-BC-HPMEGACLONE-221 can pose significant health risks. Adverse effects may include tachycardia, hypertension, hallucinations, and psychosis. Long-term use can lead to dependence and withdrawal symptoms. Due to the potential for severe side effects, caution is advised when encountering this substance.

Detection and Analysis

Detection of CUMYL-BC-HPMEGACLONE-221 in biological samples can be challenging due to its synthetic nature and the constant evolution of new analogs. Advanced analytical techniques such as mass spectrometry and gas chromatography are often employed to identify and quantify this compound in forensic and clinical settings.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• Designer drugs